scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1003576952 |
P356 | DOI | 10.1007/S00296-011-2238-7 |
P698 | PubMed publication ID | 22147110 |
P2093 | author name string | Andreas Hahn | |
Janina Willers | |||
P2860 | cites work | Prediction of Coronary Heart Disease Using Risk Factor Categories | Q22241923 |
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure | Q22306384 | ||
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE> | Q28204197 | ||
EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis | Q33505914 | ||
Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology | Q33740111 | ||
New insights into the pathogenesis of rheumatoid arthritis | Q34042699 | ||
The effect of pharmacological therapy on the cardiovascular system of patients with systemic rheumatic diseases | Q34129198 | ||
Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis | Q34182804 | ||
Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project | Q34534248 | ||
Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies | Q34889152 | ||
Cardiovascular admissions and mortality in an inception cohort of patients with rheumatoid arthritis with onset in the 1980s and 1990s | Q35554980 | ||
Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host | Q35753611 | ||
Role of cytokines in cardiovascular diseases: a focus on endothelial responses to inflammation | Q35947274 | ||
Mortality in established rheumatoid arthritis. | Q36942644 | ||
Measuring subclinical atherosclerosis: is homocysteine relevant? | Q36996494 | ||
Traditional cardiovascular risk factors in rheumatoid arthritis: a meta-analysis | Q37790040 | ||
Vascular function and morphology in rheumatoid arthritis: a systematic review | Q37934239 | ||
The risk of myocardial infarction and pharmacologic and nonpharmacologic myocardial infarction predictors in rheumatoid arthritis: a cohort and nested case-control analysis | Q40053146 | ||
Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Münster (PROCAM) study | Q40664994 | ||
C-reactive protein: adjunct to cardiovascular risk assessment. | Q43003437 | ||
Influence of anti-tumour necrosis factor therapy on cardiovascular risk factors in patients with active rheumatoid arthritis | Q43049221 | ||
Methotrexate effects in patients with rheumatoid arthritis with cardiovascular comorbidity | Q43483478 | ||
Prevalence and predictive factors of comorbidity in rheumatoid arthritis patients monitored prospectively from disease onset up to 20 years: lack of association between inflammation and cardiovascular disease | Q44051899 | ||
Lp(a) lipoprotein and lipids in patients with rheumatoid arthritis: serum levels and relationship to inflammation | Q45004490 | ||
Folate, homocysteine, and cobalamin status in patients with rheumatoid arthritis treated with methotrexate, and the effect of low dose folic acid supplement | Q45167242 | ||
Assessment of cardiovascular risk--PROCAM and new algorithms | Q46665154 | ||
How much of the increased incidence of heart failure in rheumatoid arthritis is attributable to traditional cardiovascular risk factors and ischemic heart disease? | Q46732422 | ||
Cardiovascular risk profile in systemic lupus erythematosus and rheumatoid arthritis: a comparative study of female patients. | Q51535779 | ||
Differences in atherosclerotic coronary heart disease between subjects with and without rheumatoid arthritis. | Q51761535 | ||
Accelerated atherosclerosis in pre-menopausal female patients with rheumatoid arthritis. | Q51787678 | ||
Rheumatoid arthritis | Q56656479 | ||
Nails in the coffin: increasing evidence for the role of rheumatic disease in the cardiovascular mortality of rheumatoid arthritis | Q77406796 | ||
High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors | Q77406810 | ||
Increased coronary-artery atherosclerosis in rheumatoid arthritis: relationship to disease duration and cardiovascular risk factors | Q81300622 | ||
P433 | issue | 12 | |
P921 | main subject | rheumatoid arthritis | Q187255 |
P304 | page(s) | 3741-3749 | |
P577 | publication date | 2011-11-16 | |
P1433 | published in | Rheumatology International | Q15763689 |
P1476 | title | Cardiovascular risk in patients with rheumatoid arthritis: assessment of several traditional risk parameters and a German risk score model | |
P478 | volume | 32 |
Q89891732 | Association of Serum Folate Levels With Cardiovascular Mortality Among Adults With Rheumatoid Arthritis |
Q28082992 | Cardiovascular disease risk scores in the current practice: which to use in rheumatoid arthritis? |
Q34081242 | Cardiovascular involvement in autoimmune diseases |
Q36205262 | Symmetric Dimethylarginine Is Not Associated with Cumulative Inflammatory Load or Classical Cardiovascular Risk Factors in Rheumatoid Arthritis: A 6-Year Follow-Up Study |